January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
5 Articles in Immunotherapy suggested by Wafik El-Deiry
Jan 26, 2025, 14:04

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.

Wafik El-Deiry

Wafik El-Deiry shared a few must-reads paper on X:

Imatinib and the dawn of precision cancer therapy

Author: Brian J. Druker

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer

Authors: Ema Mitsui et al.

 Wafik El-Deiry

Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells

Authors: Martina Sanlorenzo et al.

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial

Authors: Christian Kurzeder et al.

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD

Authors: Mayra Shanley  et al.

5 Articles in Immunotherapy suggested by Wafik El-Deiry